Aurium Pharma

Aurium Pharma is a Canadian specialty pharmaceutical company focused on the licensing, acquisition, and commercialization of innovative healthcare products. The company specializes in therapeutic areas such as dermatology, respiratory health, and ophthalmology, managing a portfolio of clinically proven brands including Kelo-cote and Helixia. Aurium partners with international manufacturers to navigate the Canadian regulatory landscape and bring specialized treatments to the domestic market. Their business model emphasizes commercial excellence and strategic partnerships within the retail pharmacy and professional healthcare channels. The company is headquartered in Milton, Ontario, and serves as a key bridge for global pharmaceutical innovation entering Canada.